A Study to Evaluate the Safety, Tolerability, and Effects of Anatabloc® Crème in Rosacea

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2012
This is a multi-site, four-visit, eight-week, double-blind, randomized, vehicle-controlled, parallel-group study followed by an eight-week open-label extension to evaluate the safety, tolerability, and potential effects of Anatabloc Facial Cream. The secondary aim is to evaluate if Anatabloc Facial Cream improves the appearance of the skin in subjects with mild to moderate rosacea.
Epistemonikos ID: 1752a1077367538279e00b4b09ec28272c837cff
First added on: May 11, 2024